NCT04084249View on ClinicalTrials.gov

ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

359

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Colorectal CancerColo-rectal CancerctDNAGastro-Intestinal DisorderColorectal NeoplasmsGastrointestinal CancerGastrointestinal NeoplasmsDigestive System DiseaseDigestive System NeoplasmColonic DiseasesColonic NeoplasmsColonic CancerRectal DiseasesRectal NeoplasmsRectal Cancer
Interventions
DIAGNOSTIC_TEST

ctDNA-analysis

Minimally-invasive blood-based analysis of circulating tumor DNA (ctDNA).

OTHER

Intensified Follow-up Schedule

PET/CT-scans every 3. month

Trial Locations (10)

2400

Bispebjerg Hospital, Copenhagen

2730

Herlev Hospital, Herlev

4600

Zealand University Hospital, Køge

5000

Odense University Hospital, Odense

7400

Gødstrup Hospital, Herning

8000

Aarhus University Hospital, Aarhus

8700

Regional Hospital Horsens, Horsens

8800

Regional Hospital Viborg, Viborg

8930

Regional Hospital Randers, Randers

9000

Aalborg University Hospital, Aalborg

All Listed Sponsors
collaborator

University of Aarhus

OTHER

lead

Claus Lindbjerg Andersen

OTHER